IQVIA Holdings Inc. (NYSE:IQV) Shares Purchased by Marks Group Wealth Management Inc

Marks Group Wealth Management Inc grew its stake in shares of IQVIA Holdings Inc. (NYSE:IQV) by 2.0% in the third quarter, HoldingsChannel reports. The fund owned 34,602 shares of the medical research company’s stock after buying an additional 678 shares during the quarter. Marks Group Wealth Management Inc’s holdings in IQVIA were worth $8,200,000 at the end of the most recent quarter.

Several other large investors have also modified their holdings of the stock. Canada Pension Plan Investment Board increased its position in IQVIA by 6.6% during the second quarter. Canada Pension Plan Investment Board now owns 3,403,488 shares of the medical research company’s stock worth $719,634,000 after purchasing an additional 211,653 shares during the last quarter. Lazard Asset Management LLC grew its stake in shares of IQVIA by 0.9% during the 1st quarter. Lazard Asset Management LLC now owns 3,263,944 shares of the medical research company’s stock valued at $825,416,000 after buying an additional 30,014 shares during the period. Farallon Capital Management LLC increased its holdings in shares of IQVIA by 3.1% during the 2nd quarter. Farallon Capital Management LLC now owns 2,923,032 shares of the medical research company’s stock worth $618,046,000 after buying an additional 86,870 shares during the last quarter. Mitsubishi UFJ Asset Management Co. Ltd. raised its position in shares of IQVIA by 3.8% in the 1st quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 2,510,685 shares of the medical research company’s stock worth $634,927,000 after buying an additional 92,293 shares during the period. Finally, Capital Research Global Investors boosted its holdings in IQVIA by 7.2% in the first quarter. Capital Research Global Investors now owns 2,138,802 shares of the medical research company’s stock valued at $540,882,000 after acquiring an additional 143,533 shares during the last quarter. 89.62% of the stock is currently owned by hedge funds and other institutional investors.

IQVIA Stock Up 1.3 %

Shares of NYSE IQV opened at $212.96 on Wednesday. The firm has a market cap of $38.65 billion, a price-to-earnings ratio of 27.95, a PEG ratio of 2.07 and a beta of 1.51. IQVIA Holdings Inc. has a 1 year low of $190.20 and a 1 year high of $261.73. The company has a debt-to-equity ratio of 1.76, a quick ratio of 0.81 and a current ratio of 0.81. The stock’s 50-day simple moving average is $232.84 and its 200-day simple moving average is $229.54.

Analysts Set New Price Targets

A number of research firms have recently commented on IQV. Deutsche Bank Aktiengesellschaft cut their price objective on IQVIA from $270.00 to $265.00 and set a “buy” rating on the stock in a report on Friday, November 1st. Morgan Stanley dropped their target price on shares of IQVIA from $280.00 to $265.00 and set an “overweight” rating for the company in a research report on Monday. StockNews.com raised shares of IQVIA from a “hold” rating to a “buy” rating in a research report on Wednesday, October 30th. Robert W. Baird dropped their price objective on shares of IQVIA from $256.00 to $223.00 and set a “neutral” rating for the company in a research report on Friday, November 1st. Finally, Evercore ISI cut their target price on shares of IQVIA from $270.00 to $265.00 and set an “outperform” rating on the stock in a research note on Tuesday, October 8th. Four analysts have rated the stock with a hold rating, fifteen have issued a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $259.13.

Insiders Place Their Bets

In other news, insider Eric Sherbet sold 1,300 shares of the stock in a transaction that occurred on Tuesday, August 27th. The stock was sold at an average price of $246.33, for a total transaction of $320,229.00. Following the completion of the transaction, the insider now directly owns 19,536 shares in the company, valued at approximately $4,812,302.88. This represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. 1.60% of the stock is owned by company insiders.

IQVIA Company Profile

IQVIA Holdings Inc engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.